Latest Therapeutic Goods Administration News | Page 2

Stronger regulation needed to address injectable peptide craze
Higher-strength medicinal cannabis may be linked to a disturbing pattern of side effects, our study shows
Efficacy Of Listed Medicines For Exercise Performance
Can’t get your HRT patches? What to do and what to avoid
Indian national charged over alleged tobacco profits and visa-related offences
Updates to the List of Australian Manufacturers Licensed by the TGA
New research raises concerns about safety of higher-THC medicinal cannabis products in Australia
Tighter regulatory controls of nicotine pouches needed to avoid harm
Australian Government’s hardline stance on illicit tobacco reinforced by multi-agency success
NSW And ACT Target For Illicit Tobacco Strike
TGA issues infringement notices for alleged unlawful advertising of therapeutic goods involving prohibited representations
Veganic SKN directed to cease supply and relabel or destroy unapproved sunscreens
Enforceable Direction: Veganic SKN Limited
AFP confiscates more than $1 million linked to illicit vape sales
Inclusive assessments allow more Canberrans to donate blood
Over 30,000 illegal vaping goods seized in major TGA operation in south-west Sydney
Three Victorians arrested following seizure of over $2 million worth of steroids and peptides by the ABF and TGA
Will retatrutide help me lose weight or look ‘shredded’?
Consumer patient information materials for implantable devices
Therapeutic goods are not affected by the Industrial Chemicals Environmental Management Standard (IChEMS)
Injectable peptides are the new anti-ageing trend. But what evidence do we have they’re safe for humans?
Should clinics prescribe medicinal cannabis that they also supply? We asked 5 experts
Can medicinal cannabis help kids’ autism, ADHD or Tourette’s? Here’s what we know so far
As the Iran war disrupts supplies, will it affect access to medicines?
Will medicinal cannabis help my mental health? Here are the evidence and the risks
Listed Medicine Compliance Reports – March 2026 Update
The TGA wants to overhaul sunscreen labels. Will scrapping SPFs work?
Earlier, Faster, And Fairer Access To New Medicines
TGA issues infringement notices to 3 health practitioners for alleged unlawful importation of therapeutic goods
Improving Regulation Of Sunscreens In Australia
Medicinal cannabis has gone mainstream. But Australia’s struggling to cope
TGA Product Information Safety Updates 23 March
What does One Nation actually believe in?
View New National Clinical Governance Committee for Digital Health drives collaboration and clinical safety
Women’s health is not a pilot project”: RACGP on Government decision to prioritise political donations over safety
National Disruption Group nets millions with major multi-state success
New project to expand pioneering cellular immunotherapy technology to India
More than 650 gather for AusBiotech and Medicines Australia Women in Life Sciences Luncheon & Leadership Summit
TGA ignored as Victorian Government ‘shortcut’ puts women at risk: RACGP
Peptides And Social Media
GMP Annex 6 and Annex 15 concept papers – Open for public consultation
Update To Listed Medicine Ingredients In March 2026
TGA Product Information Safety Updates 25 February
New Resources On Market Actions And Minor PRAC Updates
Bernard Lane exposes regulator “flying blind” on puberty blockers – ban the child gender experiment now
What are the current guidelines for early prostate cancer detection in Australia?
New Documentary: Prescription for Violence – Psychiatry’s Deadly Side Effects: TGA Issues Homicidal Ideation Warning for ADHD Drug
Medicines Containing Vitamin B6